Lyne Lalonde

Université de Montréal — Canada

Medicine · Health Sciences

31h-index2.6kcitations87works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Practices and Patient Outcomes(38), Health Systems, Economic Evaluations, Quality of Life(20), Medication Adherence and Compliance(19), Blood Pressure and Hypertension Studies(13), Atrial Fibrillation Management and Outcomes(8)

Publications87 total

A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial
Pilot and Feasibility Studies·2025Open Access
Un monde sans la <i>Revue des Pharmaciens du Canada – Canadian Pharmacists Journal</i> . . .
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada·2025Open Access
A world without the <i>Canadian Pharmacists Journal – Revue des Pharmaciens du Canada. . .</i>
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada·2025Open Access
Pharmacists practising in family medicine groups: An evaluation 2 years after experiencing a virtual community of practice
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada·2021· 8 citedOpen Access
Pharmacists practising in family medicine groups: What are their activities and needs?
Journal of Clinical Pharmacy and Therapeutics·2019· 24 cited
Concordance of care processes between medical records and patient self-administered questionnaires
BMC Family Practice·2019· 6 citedOpen Access
Development and validation of PART (Pharmacotherapy Assessment in Renal Transplant Patients) criteria to assess drug‐related problems in an outpatient renal transplant population: A cross‐sectional study
Pharmacology Research & Perspectives·2019· 6 citedOpen Access
Lasso Regression for the Prediction of Intermediate Outcomes Related to Cardiovascular Disease Prevention Using the TRANSIT Quality Indicators
Medical Care·2018· 23 cited
Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network
Journal of Clinical Pharmacy and Therapeutics·2018· 4 cited
Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study
Research in Social and Administrative Pharmacy·2018· 11 cited
Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation
Journal of Managed Care & Specialty Pharmacy·2018· 9 citedOpen Access
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study
Clinical Cardiology·2018· 22 citedOpen Access
Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies
Journal of Managed Care & Specialty Pharmacy·2018· 37 citedOpen Access
Psychometric analysis of the TRANSIT quality indicators for cardiovascular disease prevention in primary care
International Journal for Quality in Health Care·2017· 2 citedOpen Access
Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial
American Journal of Kidney Diseases·2017· 36 cited
Kidney Transplant Recipients' Perspectives on Cardiovascular Disease and Related Risk Factors After Transplantation: A Qualitative Study
Transplantation Direct·2017· 8 citedOpen Access
Identifying heavy health care users among primary care patients with chronic non-cancer pain
Canadian Journal of Pain·2017· 10 citedOpen Access
Evaluation of a continuous quality improvement program in anticoagulant therapy
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada·2016· 2 citedOpen Access
External facilitators and interprofessional facilitation teams: a qualitative study of their roles in supporting practice change
Implementation Science·2015· 90 citedOpen Access
Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective
American Journal of Health-System Pharmacy·2015· 10 cited
page 1 of 5Next →

Frequent Co-authors

Sylvie Perreault(19), Lucie Blais(14), Djamal Berbiche(14), Alice Dragomir(8), Éveline Hudon(7), Steven A. Grover(7), Diane Lamarre(7), Anne Lord(7), Marie‐Thérèse Lussier(6), Johanne Goudreau(6), Marie‐Claude Vanier(6), Manon Choinière(6), Robert Côté(5), Marie-Claude Laliberté(5), Céline Bareil(5), Lise Lévesque(5), Josée Martineau(4), Normand Blais(4), Anick Bérard(4), Michel White(4)